Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Wins $100K SBIR Grant to Develop Algorithms for Disease Pathway Reconstruction

NEW YORK, June 13 (GenomeWeb News) - GeneGo has received a Phase I Small Business Innovation Research grant from the National Institute of General Medical Science to develop computational methods for reconstructing pathways in human diseases, the St. Joseph, Mich.-based company said today.

 

The company did not mention the amount of the award, but NIH databases list a six-month $99,324 grant for GeneGo entitled "Computational Reconstruction of Disease Pathways" that started June 1.

 

During Phase I of the grant, GeneGo plans to develop several algorithms to reconstruct condition-specific pathways automatically, based on large sets of high-throughput molecular data, and to test them using microarray data from cancer cell lines provided by collaborators at the Van Andel Research Institute.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.